Yervoy IV infusion (ipilimumab) — Uses, Dosage, Side Effects & Safety
Drug class: Cancer & Oncology
Overview
Yervoy IV infusion (ipilimumab) is a prescription medicine used to treat certain types of cancer, most commonly advanced melanoma, as well as renal cell carcinoma and colorectal cancer in combination with other drugs. It works by helping your immune system recognize and attack cancer cells more effectively. Yervoy belongs to a class of medicines called immune checkpoint inhibitors. It blocks a protein called CTLA-4 on T-cells, which normally acts as a brake on the immune response. By blocking this protein, Yervoy allows your immune system to better target and destroy cancer cells. Key points for patients: Yervoy is given as an intravenous (IV) infusion in a hospital or clinic, usually every 3 or 4 weeks. It can cause immune-related side effects, so regular monitoring is important. Always report any new symptoms to your healthcare provider promptly.
Therapeutic uses
- Unresectable or metastatic melanoma
- Adjuvant treatment of cutaneous melanoma with pathologic involvement of regional lymph nodes of >1 mm
- First-line treatment of metastatic renal cell carcinoma (RCC) in intermediate or poor risk patients (in combination with nivolumab)
- Treatment of metastatic colorectal cancer (CRC) that is microsatellite instability-high (MSI-H) or mismatch repair deficient (dMMR) (in combination with nivolumab)
- Treatment of hepatocellular carcinoma (HCC) in patients who have been previously treated with sorafenib (in combination with nivolumab)
Common side effects
- Fatigue
- Diarrhea
- Nausea
- Vomiting
- Rash
- Colitis
- Hepatitis
- Endocrinopathies
Frequently Asked Questions about Yervoy IV infusion
What types of cancer is Yervoy used to treat?
Yervoy is approved for advanced melanoma, renal cell carcinoma, and certain colorectal cancers, often in combination with other immunotherapies.
How is Yervoy administered?
Yervoy is given as an intravenous infusion by a healthcare professional, usually every 3 or 4 weeks.
What are the most serious side effects of Yervoy?
Serious side effects include severe diarrhea/colitis, hepatitis, endocrinopathies (such as thyroid or pituitary problems), severe skin reactions, and nerve inflammation.
Can I take Yervoy if I am pregnant or breastfeeding?
Yervoy is not recommended during pregnancy or breastfeeding due to potential risks to the baby.
What should I do if I miss a dose?
Contact your healthcare provider immediately to reschedule your infusion. Do not attempt to self-administer or double up on doses.
Are there any foods or medicines I should avoid while on Yervoy?
Avoid live vaccines and discuss all medications and supplements with your doctor before starting them.
How long does it take for Yervoy to start working?
Response times vary, but some patients may begin to see effects within a few weeks to months after starting treatment.
Related Yervoy IV infusion information
Educational information only. Always consult a qualified healthcare professional before starting, stopping, or changing any medication.